NCT05329376

Brief Summary

BACKGROUD: Health technology is an important tool in the aging process, which may improve the health condition and self-esteem of the elderly, in addition to offering new opportunities and challenges. In this scenario, the use of virtual interaction systems emerge as promising alternatives for the old adults, which often deals with the lack of social interaction, cognitive decline and decline in functional capacity, making the control of chronic diseases, such as diabetes, a challenge. OBJECTIVES: This project aims to evaluate the effectiveness of using an interactive virtual assistance system in mental health parameters, glycemic profile and diabetes selfcare behavior in elderly people with diabetes. METHODS: A randomized clinical trial is proposed, for an intervention that includes 3 months of use of the Smart Speaker Echo Dot system, programmed to provide reminders, stimulate treatment records and maintain healthy habits. Outcomes assessed will include parameters of mental health and diabetes control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

June 20, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2024

Completed
Last Updated

May 22, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

March 14, 2022

Last Update Submit

May 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Screening for depression, anxiety and common mental health disorders in elderly

    For mental health screening, the Self Report Questionnaire (SRQ 20) will be used, translated into Portuguese and validated for the Brazilian population. It is a questionnaire with 20 questions specially developed for the screening of depression, anxiety em common mental health disorders in the elderly. Higher scores indicating more mental distress.

    Change from baseline to 12 weeks

Secondary Outcomes (7)

  • Glycemic control: glycated hemoglobin (HbA1c) assessment

    Change from baseline to 12 weeks

  • Variation in systolic blood pressure

    Change from baseline to 12 weeks

  • Variation in diastolic blood pressure

    Change from baseline to 12 weeks

  • Variation in total cholesterol

    Change from baseline to 12 weeks

  • Adherence parameters and self-care in the treatment of diabetes

    Change from baseline to 12 weeks

  • +2 more secondary outcomes

Study Arms (2)

Group A

EXPERIMENTAL

12 weeks of daily interactions with Smart Speaker EchoDot 3rd Gen (Amazon Echo®).

Device: Smart Speaker Echo Dot

Group B

OTHER

12 weeks of maintenance of usual care.

Other: Usual Care

Interventions

Participants will receive the Smart Speaker EchoDot 3rd Gen (Amazon Echo®) device (i.e., Alexa) for home use, installed during a home visit following the study enrollment. In addition to the usual functionality of the system, the device will be programmed using a standard model developed by the research team, applied to each patient. The proposed model involves automatic interactions between the device and the patient, comprising: 1. Medication reminders 2. Glucose test reminders: 3. Educational health tips 4. Weekly educational podcasts 5. Good morning and good night routine

Group A

Participants will maintain usual care during the study period and will receive a booklet with general advice following enrollment

Group B

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Being 65 years of age or older;
  • Having a diagnosis of type 2 diabetes;
  • Residing in Porto Alegre or metropolitan region;
  • Presenting availability of Wi-Fi connection at home; and
  • Presenting availability to participate in the proposed face-to-face evaluation and accept receiving one visit for installation of the device.

You may not qualify if:

  • Having an interactive virtual home assistance device at the time of enrollment;
  • Having cognitive impairments or severe hearing impairments that prevent adequate interaction with outcome assessors and the application of follow-up questionnaires; or
  • Residing in regions of difficult access.
  • Recruitment:
  • Study subjects will be recruited through two different strategies:
  • Screening of records of the outpatients clinics of Hospital São Lucas (HSL)
  • Social media advertising, specially in Instagram®

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pontifícia Universidade Católica do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, 90619-900, Brazil

Location

Related Publications (2)

  • Matzenbacher LS, da Costa FL, de Barros LGB, Gheno V, Maia IS, Blank LM, Brum MAB, Fontoura LF, Viola TW, Schwanke CHA, Gadonski G, Alessi J, Telo GH. Interactive Virtual Assistant for Health Promotion Among Older Adults With Type 2 Diabetes: The IVAM-ED Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 2;9(1):e2553508. doi: 10.1001/jamanetworkopen.2025.53508.

  • da Costa FL, Matzenbacher LS, Gheno V, Brum MAB, de Barros LGB, Maia IS, Blank LM, Fontoura LF, Alessi J, Telo GH. Interactive virtual assistance for mental health promotion and self-care management in elderly with type 2 diabetes (IVAM-ED): study protocol and statistical analysis plan for a randomized controlled trial. Trials. 2024 Mar 21;25(1):205. doi: 10.1186/s13063-024-08055-3.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2DepressionAnxiety DisordersMental DisordersFrailty

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehaviorPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2022

First Posted

April 15, 2022

Study Start

June 20, 2023

Primary Completion

May 17, 2024

Study Completion

May 17, 2024

Last Updated

May 22, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations